The largest database of trusted experimental protocols

Quantiscript reverse transcriptase

Manufactured by Qiagen
Sourced in Germany, United States

Quantiscript Reverse Transcriptase is a lab equipment product designed for the reverse transcription of RNA to cDNA. It is a highly-processive and thermostable enzyme capable of generating high-yields of cDNA from a wide range of RNA templates.

Automatically generated - may contain errors

29 protocols using quantiscript reverse transcriptase

1

Quantifying Renal Extracellular Matrix Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen samples of renal cortex were transitioned into RNAlater‐ICE (Ambion, Paisley, UK) before extraction of total RNA using an RNeasy plus mini kit (Qiagen Ltd, Manchester, UK). RNA extracts were treated with gDNA wipe‐out buffer (Qiagen) before reverse transcription using QuantiScript reverse transcriptase (Qiagen). Messenger RNA for Col4a1 (collagen IV alpha 1), Lamb1 (laminin‐β1) and Fn1 (fibronectin 1) were quantified in a 1:100 dilution of cDNA using a Stratgene Mx3000/3005P real‐time PCR machine (Agilent Technologies, Stockport, UK) and QuantiFast SYBR Green PCR mix (Qiagen) with ROX reference dye. Primers were provided in QuantiTect Primer Assay kits QT01620073, QT01574531 and QT00179333 (Qiagen) for Col4a1, Lamb1 and Fn1, respectively. Messenger RNAs were quantified against standard curves generated from pooled cDNA and normalized to expression of the housekeeping genes Ywhaz (tyrosine 3‐monooxygenase/tryptophan 5‐monooxygenase activation protein, zeta) and B2m (β2 microglobulin).
+ Open protocol
+ Expand
2

Evaluating adeB Expression by qRT-PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression of adeB was evaluated by qRT-PCR as described previously (32 (link)). rpoB was used as a reference gene, and its expression was quantified concurrently with adeB expression. Primers used for the amplification of adeB and rpoB are listed in Table S1. Freshly prepared RNA (RNeasy; Qiagen) and cDNA (Quantiscript reverse transcriptase; Qiagen) were used to perform qRT-PCR with SYBR green master mix (Qiagen) in triplicates, and the experiment was repeated independently at least three times. The number of adeB transcripts in ATCC 17978 ΔadeRS pJN17/04::adeRSACICU (here referred to as 17978 adeR-wt), pJN17/04::adeR(D26N)SACICU (here referred to as 17978 adeR-D26N), pJN17/04::adeR(D21V)SACICU (here referred to as 17978 adeR-D21V), and pJN17/04::adeR(D21V, D26N)SACICU (here referred to as 17978 adeR-D21V+D26N) transformants were compared with each other. In a separate experiment, the number of adeB transcripts was compared between isolate ABC153 and ABC154.
Statistical analysis was performed via GraphPad Prism 9.2.0 (San Diego, California USA) with an unpaired t test using the recorded absolute values.
+ Open protocol
+ Expand
3

Quantitative Gene Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from tumor tissues using RNeasy Mini kit (Qiagen, #74104) as previously described.23 (link) RNA concentration and purity were determined by Q5000 nanodrop (Quawell) and by running in 1% gel electrophoresis. The cDNA was synthesized by reverse transcription of RNA (5 μg) using Quantiscript reverse transcriptase (Qiagen, #205310). Specific primers for Bax, Bcl2, NFKb, IL1β, iNOS, VEGF, MMP9, and ICAM1 genes were designed by the Primer 3 web-based tool based on the published rat sequences (Table 1). Quantitative real-time PCR (qPCR) was performed using QuantiTect SYBR Green qPCR Master Mix in a StepOnePlus real-time PCR system (Applied Biosystems) and reaction cycles as previously described.24 (link) The quantities critical threshold (Ct) of target gene were normalized with quantities (Ct) of the internal control (β actin) as previously described.25 (link) Levels were expressed relative to normal control samples.
+ Open protocol
+ Expand
4

Analysis of Apoptosis-Related Genes in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of Bcl2, Survivin, cIAP, XIAP, GCLC (glutamate-cysteine ligase catalytic subunit) and GAPDH was analyzed in MCF-7 and U87 cells after the treatment with PRE, EA, Hex and mixture of EC+GA+UA. Total RNA was extracted from cells using RNAeasy kit (Qiagen GmbH, Hilden Germany). cDNAs were reverse transcribed from 1 μg of total RNA from each sample using Quantiscript Reverse Transcriptase, Quantiscript-RT-buffer and RT-primer-mix of QuantiTect Reverse Transcription kit (Qiagen GmbH, Hilden Germany) according to the manufacturer’s protocol.
Amplification of cDNA was carried out in 20 μl solution containing 2 μl cDNA, 10 pmol primer pairs for Bcl2, Survivin, XIAP, cIAP and GAPDH (for primer sequences- Table A in S1 File) and 10 μl of RT qPCR Master mix (Qiagen GmbH, Hilden, Germany). The PCR consisted of initial denaturation at 94°C for 5 min, followed by 25 reaction cycles (30 seconds at 94°C, 30 seconds at 60°C, and 30 seconds at 72°C) and a final cycle at 72°C for 10 min. GAPDH was used as internal control. The amplified PCR products were separated by agarose gel electrophoresis and visualized with ethydium bromide. The abundance of each target mRNA was detected and normalized to that of GAPDH mRNA.
+ Open protocol
+ Expand
5

Quantitative Assessment of Cathepsin Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted from the MDA-MB-231 epithelial, human breast cell line using an RNeasy mini kit (Qiagen, Venlo, Netherlands‎). First-strand cDNA was synthesized from 1 µg of total RNA using 1 µL of Quantiscript Reverse Transcriptase (Qiagen) according to the manufacturer’s protocol. PCR amplification was conducted using the following conditions: 40 cycles of 95 °C for 1 min, 55 °C for 90 s, and 72 °C for 1 min followed by a final incubation at 72 °C for 5 min. Primer sequences for target genes were as follows: cathepsin S forward GGGTACCTCATGTGACAAG and reverse TCACTTCTTCACTGGTCATG, cathepsin L forward ATGAATCCTACACTCATCCTTGC and reverse TCACACAGTGGGGTAGCTGGCTGCTG, cathepsin K forward ATGTGGGGGCTCAAGGTTCTGC and reverse TCACATCTTGGGGAAGCTGGCC, cathepsin V forward ATGAATCTTTCGCTCGTCCTGGC and reverse TCACACATTGGGGTAGCTGGC, and actin forward ATCTGGCACCACACCTTCTACAATGAGCTGCG and reverse CGTCATACTCCTGCTTGCTG ATCCACATCTGC.
+ Open protocol
+ Expand
6

RNA Extraction and Reverse Transcription

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was eliminated from the DNA with a mixture of gDNA Wipeout Buffer and RNPASE free water incubated for 2 min at 42°C. Then, 1 µg of total RNA was reverse transcribed using Quantiscript Reverse Transcriptase for 15 min at 42°C and 3 min at 95°C (Qiagen, Sciences, Maryland, USA).
+ Open protocol
+ Expand
7

Quantitative Analysis of erg1 mRNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure erg1 mRNA levels of target strains, cells were cultivated until log phase was reached in YES media, harvested using conical tubes, and subjected to RT-PCR. In brief, mRNA was extracted using TRIzol reagent (Thermo Fisher Scientific) and reverse transcribed to cDNA using the Quantiscript Reverse Transcriptase (Qiagen, Hilden, Germany). cDNA (100 ng) was then amplified using iQ SYBR Green Supermix, and measured on a CFX ConnectTM Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA). Actin was used as an endogenous control for normalization. The primer sequences were as follows: erg1: forward, 5′-CGCTATATGAAGGCTCTTGAATCG-3′ and reverse, 5′-GATGAGAAGGGCTATGGTCTAAAC-3′; act1: forward, 5′-TCCAACCGTGAGAAGATGACT-3′ and reverse, 5′-CGACCAGAGGCATACAAAGAC-3′.
+ Open protocol
+ Expand
8

Peripheral Blood RNA Extraction and cDNA Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
PAX gene blood ribonucleic acid (RNA) tubes (Qiagen, Tokyo, Japan) and PAX gene Blood RNA kits (Qiagen) were used according to the manufacturer’s recommendations to extract total RNA from peripheral leukocytes taken from whole blood samples. After assessing RNA quality and quantity, individual total RNA samples (2 μm each), random (N6) primers, and Quantiscript Reverse Transcriptase (Qiagen, Tokyo, Japan) were used to synthesize complementary deoxyribonucleic acids (cDNAs).
+ Open protocol
+ Expand
9

Validating RNA-Seq Data with qPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
The validation of RNA-Seq data was carried out on a set of DE genes using the quantitative real-time polymerase chain reaction (qPCR) technique. RNA was extracted from independent biological samples collected at the same stage than the ones used for RNA-Seq analysis. The reverse transcription of RNA samples was performed with the QuantiTect Reverse Transcription Kit (Qiagen) and the Quantiscript Reverse Transcriptase (Qiagen). Specific primers for 15 selected genes were designed with Primer3web version 4.0.0 (Additional file 11: Table S5). qPCR reactions, conditions, and calculation of relative expression values were carried out as in Falginella et al. [63 (link)]. The annealing temperature was 58 °C for all primer pairs except the VviUbiquitin housekeeping gene pair, which annealed at 56 °C. Correlation analysis based on the Pearson Correlation Coefficient (PCC) was carried out between the RNA-seq normalized counts and qPCR relative gene expression (Additional file 11: Table S5, Additional file 12: Figure S6).
qPCR was also carried out to determine the level of expression of selected structural genes of the phenylpropanoid, flavonoid, and terpenoid pathway at each sampling date.
+ Open protocol
+ Expand
10

Quantitative Analysis of Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from liver tissue (either fresh or frozen) using RNeasy Mini kit (Qiagen, #74104) and as previously described [39 (link)]. The cDNA was synthesized by reverse transcription of RNA using Quantiscript reverse transcriptase according to the manufacturer's instructions (Qiagen, #205310). Specific primers for Bax, p53, Bcl2, TGFβ1, NFκB, VEGF, MMP9, and TIMP1 genes were designed by the Primer 3 web-based tool based on the published rat sequence (Table 1). lncTuc339, lncHEIH, and lncHOTAIR were obtained from RiboBio (Guangzhou, China). Quantitative real-time PCR (qPCR) was performed using QuantiTect SYBR Green qPCR Master Mix in a StepOnePlus Real-Time PCR system (Applied Biosystems, USA) and reaction cycles as previously described [40 (link)]. The quantities of the critical threshold (Ct) of target genes were normalized with quantities (Ct) of the internal control (β-actin) as previously described [41 (link)]. Levels were expressed relative to normal control samples.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!